Skip to content

A clinical study of remifentanil versus propofol in the treatment of emergence agitation in adults

A clinical study of remifentanil versus propofol in the treatment of emergence agitation in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057412
Enrollment
Unknown
Registered
2022-03-11
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

emergence agitation

Interventions

Remifentanil treatment group:Remifentanil treatment
Propofol treatment group:Propofol treatment

Sponsors

The First Affiliated Hospital of USTC
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with restlessness in the resuscitation room after elective general anesthesia; 2. 18 = 65; 3. 18 kg/m2 < body mass index (BMI) < 30 kg/m2; 4. American Society of Anesthesiologists (ASA) Grade I~III.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot communicate normally before operation; 2. Patients with mental illness; 3. Grade II and above atrioventricular block, bradycardia (HR<50 points/time), hypotension (NBP<90/60mmHg); 4. Patients with hypertension and poor blood pressure control (systolic blood pressure = 160mmHg or diastolic blood pressure = 110mmHg); 5. Patients with a history of opiate allergy or addiction; 6. Patients allergic to propofol; 7. Patients who are given muscle relaxants within 30 minutes after

Design outcomes

Primary

MeasureTime frame
A recurrent emergence agitation within 15 min after intervention.;

Secondary

MeasureTime frame
Riker sedation-agitation (RSAS) score after treatment at different time points.;Patient's vital signs (blood pressure, heart rate, blood oxygen saturation) at different time points;Coughing response during emergence;Time to remove the tracheal tube;Proportion of patients with PONV;Numerical Rating Scale (NRS) and rescue medication;Adverse events in the PACU;Time to discharge from the PACU;

Countries

China

Contacts

Public ContactWang Sheng

The First Affiliated Hospital of USTC

iamsheng2020@ustc.edu.cn+86 19156007726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026